| Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics | 2010/02/01 | English | 135 |
| Graphic Rule for Drug Metabolism Systems | 2010/05/01 | English | 134 |
| Calcium Metabolism and Oxidative Stress in Bone Fractures: Role of Antioxidants | 2007/06/01 | English | 133 |
| The Impact of Probiotic on Gut Health | 2009/01/01 | English | 133 |
| CSF as a Surrogate for Assessing CNS Exposure: An Industrial Perspective | 2008/01/01 | English | 131 |
| Bioactivation and Hepatotoxicity of Nitroaromatic Drugs | 2006/10/01 | English | 129 |
| Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions | 2008/06/01 | English | 128 |
| Gallic Acid and Gallic Acid Derivatives: Effects on Drug Metabolizing Enzymes | 2003/06/01 | English | 127 |
| Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells | 2002/10/01 | English | 126 |
| Cytochrome P450 Regulation and Drug Biotransformation During Inflammation and Infection | 2004/06/01 | English | 125 |
| Cytochrome P450 and Liver Diseases | 2004/06/01 | English | 123 |
| Butyrate and Colorectal Cancer: The Role of Butyrate Transport | 2013/10/01 | English | 123 |
| Clinical Pharmacogenetics and Potential Application in Personalized Medicine | 2008/10/01 | English | 122 |
| Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization | 2014/03/31 | English | 121 |
| Cytochrome P450 Enzymes Mechanism Based Inhibitors: Common Sub-Structures and Reactivity | 2005/10/01 | English | 120 |
| (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Peptide Transporters: Structure, Function, Regulation and Application for Drug Delivery | 2004/02/01 | English | 119 |
| Bioavailability of Flavonoids: A Review of Their Membrane Transport and the Function of Bilitranslocase in Animal and Plant Organisms | 2009/05/01 | English | 119 |
| Regulation of Hepatic Transporters by Xenobiotic Receptors | 2005/08/01 | English | 118 |
| Chemoprotective and Carcinogenic Effects of tert-Butylhydroquinone and Its Metabolites | 2007/01/01 | English | 118 |
| Inherited Copper Transport Disorders: Biochemical Mechanisms, Diagnosis, and Treatment | 2012/03/01 | English | 118 |
| Bile Acids in Physiology, Pathology and Pharmacology | 2015/12/14 | English | 117 |
| Tetrahydrobiopterin Biosynthesis, Utilization and Pharmacological Effects | 2002/04/01 | English | 116 |
| CAR, The Continuously Advancing Receptor, in Drug Metabolism and Disease | 2005/08/01 | English | 116 |
| Heterotropic Cooperativity of Cytochrome P450 3A4 and Potential Drug-Drug Interactions | 2001/06/01 | English | 116 |
| Resveratrol: A Natural Polyphenol with Multiple Chemopreventive Properties (Review) | 2009/07/01 | English | 116 |
| Analysis of Mammalian Cytochrome P450 Structure and Function by Site-Directed Mutagenesis | 2001/06/01 | English | 115 |
| The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics | 2019/04/30 | English | 114 |
| Role of NF-κB in the Regulation of Cytochrome P450 Enzymes | 2009/02/01 | English | 114 |
| Protein-Protein Interaction (PPI) Network: Recent Advances in Drug Discovery | 2017/01/19 | English | 113 |
| Evaluation of 170 Xenobiotics as Transactivators of Human Pregnane X Receptor (hPXR) and Correlation to Known CYP3A4 Drug Interactions | 2006/05/01 | English | 112 |